The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
Open accessAbstract
Estrogen signaling pathways, because of their central role in regulating the growth and survival of breast tumor cells, have been identified as suitable and efficient targets for cancer therapies.Agents blocking estrogen activity are already widely used clinically, and many new molecules have entered clinical trials, but intrinsic or acquired resistance to treatment limits their efficacy.The basic molecular studies underlying estrogen signaling have defined the critical role of estrogen receptors (ER) in many aspects of breast tumorigenesis.However, important knowledge gaps remain about the role of posttranslational modifications (PTM) of ER in initiation and progression of breast carcinogenesis.Whereas major attention has been focused on the phosphorylation of ER, many other PTM (such as acetylation, ubiquitination, sumoylation, methylation, and palmitoylation) have been identified as events modifying ER expression and stability, subcellular localization, and sensitivity to hormonal response.This article will provide an overview of the current and emerging knowledge on ER PTM, with a particular focus on their deregulation in breast cancer.We also discuss their clinical relevance and the functional relationship between PTM.A thorough understanding of the complete picture of these modifications in ER carcinogenesis might not only open new avenues for identifying new markers for prognosis or prediction of response to endocrine therapy but also could promote the development of novel therapeutic strategies.(Endocrine Reviews 32: 597-622, 2011) I. Introduction II.Biology of Estrogen Receptors and Breast Cancer A. ER␣ and ER subtypes B. Genomic action of ER C. Nongenomic action of ER D. Endocrine therapies in breast cancer III.Posttranslational Modifications of Estrogen Receptors A. PTM involved in ER genomic signaling B. PTM involved in ER nongenomic signaling C. Molecular events affecting ER PTM D. ER PTM deregulated in breast cancer IV. Discussion V.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–255 of 255
Methylation, a key step for nongenomic estrogen signaling in breast tumors
Romancer, M. L., Treilleux, I., Bouchekioua‐Bouzaghou, K., Sentis, S., & Corbo, L. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.013 · Cited by 79
Self-citationBhat, R. A., Harnish, D. C., Stevis, P. E., Lyttle, C. R., & Komm, B. S. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00115-0 · Cited by 79
Rapid Estradiol/ERα Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells
Catalano, S., Barone, I., Giordano, C., Rizza, P., Qi, H., Gu, G., Malivindi, R., Bonofiglio, D., & Andò, S. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0039 · Cited by 78
Murphy, L. C., Niu, Y., Snell, L., & Watson, P. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0191 · Cited by 78
Williams, C. C., Basu, A., El-Gharbawy, A., Carrier, L., Smith, C. S., & Rowan, B. G. (2009) · BMC Biochemistry · doi:10.1186/1471-2091-10-36 · Cited by 77
Estrogen receptor-dependent activation of AP-1 via non-genomic signalling
Björnström, L., & Sjöberg, M. (2004) · Nuclear Receptor · doi:10.1186/1478-1336-2-3 · Cited by 76
ERα and ERβ expression and transcriptional activity are differentially regulated by HDAC inhibitors
Duong, V, Licznar, A., Margueron, R., Boulle, N., Busson, M., Lacroix, M., Katzenellenbogen, B. S., Cavaillès, V, & Lazennec, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209102 · Cited by 75
Balasenthil, S., Barnes, C. J., Rayala, S. K., & Kumar, R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.071 · Cited by 75
Epidermal Growth Factor Receptor and Tyrosine Phosphorylation of Estrogen Receptor
Márquez, D. C., Lee, J. A., Lin, T. K., & Pietras, R. J. (2001) · Endocrine · doi:10.1385/endo:16:2:073 · Cited by 75
Cracking the coregulator codes
O’Malley, B. W., Qin, J., & Lanz, R. B. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.04.005 · Cited by 74
Activation of the unliganded estrogen receptor by prolactin in breast cancer cells
González, L., Zambrano, A., Lazaro‐Trueba, I., Lopéz, E., González, J. J. A., Martín-Pérez, J., & Aranda, A. (2009) · Oncogene · doi:10.1038/onc.2008.473 · Cited by 74
Laïos, I., Journé, F., Nonclercq, D., Vidal, D. S., Toillon, R., Laurent, G., & Leclercq, G. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.02.005 · Cited by 73
Atsriku, C., Britton, D. J., Held, J. M., Schilling, B., Scott, G. K., Gibson, B. W., Benz, C. C., & Baldwin, M. A. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800282-mcp200 · Cited by 73
Azuma, K., Urano, T., Horie‐Inoue, K., Hayashi, S., Sakai, R., Ouchi, Y., & Inoue, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3458 · Cited by 71
Histone deacetylase inhibition and estrogen signalling in human breast cancer cells
Margueron, R., Duong, V., Castet‐Nicolas, A., & Cavaillès, V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.031 · Cited by 71
Cheng, J., Zhang, C., & Shapiro, D. J. (2007) · Endocrinology · doi:10.1210/en.2007-0148 · Cited by 71
Barone, I., Iacopetta, D., Covington, K. R., Cui, Y., Tsimelzon, A. I., Beyer, A. R., Andò, S., & Fuqua, S. A. W. (2010) · Oncogene · doi:10.1038/onc.2009.520 · Cited by 70
Temporal variation in estrogen receptor-α protein turnover in the presence of estrogen
Valley, C. C., Solodin, N. M., Powers, G. L., Miner, S. J., & Alarid, E. T. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0067 · Cited by 69
Splicing potentiation by growth factor signals via estrogen receptor phosphorylation
Masuhiro, Y., Mezaki, Y., Sakari, M., Takeyama, K., Yoshida, T., Inoue, K., Yanagisawa, J., Hanazawa, S., O’Malley, B. W., & Kato, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503197102 · Cited by 68
Tateishi, Y., Sonoo, R., Sekiya, Y.-I., Sunahara, N., Kawano, M., Wayama, M., Hirota, R., Kawabe, Y.-I., Murayama, A., Kato, S., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00713-06 · Cited by 68
Estrogen Receptor-α Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer
Kok, M., Holm, C., Hauptmann, M., Michalides, R. J. A. M., Stål, O., Linn, S. C., & Landberg, G. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp412 · Cited by 68
Masuyama, H., & Hiramatsu, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312762200 · Cited by 66
Gougèlet, A., Bouclier, C., Marsaud, V., Maillard, S., Mueller, S. O., Korach, K. S., & Renoir, J. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.018 · Cited by 62
Self-citationBostner, J., Skoog, L. K., Fornander, T., Nordenskjöld, B. A., & Stål, O. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1733 · Cited by 60
Glycosylation of the murine estrogen receptor-α
Cheng, X., & Hart, G. W. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00167-9 · Cited by 58
Gougèlet, A., Mueller, S. O., Korach, K. S., & Renoir, J. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.002 · Cited by 58
Self-citationGiordano, C., Cui, Y., Barone, I., Andò, S., Mancini, M. A., Berno, V., & Fuqua, S. A. W. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0334-0 · Cited by 58
Conway, K., Parrish, E., Edmiston, S. N., Tolbert, D., Tse, C., Geradts, J., Livasy, C., Singh, H. K., Newman, B. M., & Millikan, R. C. (2005) · Breast Cancer Research · doi:10.1186/bcr1315 · Cited by 57
Cellular Mechanisms Which Distinguish between Hormone‐ and Antihormone‐Activated Estrogen Receptor
McDonnell, D. P., Dana, S. L., Hoener, P. A., Lieberman, B. A., Imhof, M. O., & Stein, R. B. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31374.x · Cited by 57
He, X., Zheng, Z., Song, T., Wei, C., Ma, H., Ma, Q.-H., Zhang, Y., Xu, Y., Shi, W., Ye, Q., et al. (2010) · Oncogene · doi:10.1038/onc.2009.513 · Cited by 57
Direct interaction between estrogen receptor α and NF-κB in the nucleus of living cells
Quaedackers, M. E., van den Brink, C. E., van der Saag, P. T., & Tertoolen, L. G. J. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.002 · Cited by 56
Association between the Estrogen Receptor α A908G Mutation and Outcomes in Invasive Breast Cancer
Herynk, M. H., Parra, I., Cui, Y., Beyer, A. R., Wu, M.-F., Hilsenbeck, S. G., & Fuqua, S. A. W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2608 · Cited by 54
Skliris, G. P., Nugent, Z. J., Rowan, B. G., Penner, C. R., Watson, P. H., & Murphy, L. C. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0030 · Cited by 54
Kok, M., Zwart, W. T., Holm, C., Fles, R., Hauptmann, M., Veer, L. J. V., Wessels, L. F. A., Neefjes, J., Stål, O., Linn, S. C., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0798-y · Cited by 53
Protein Phosphatase 5 Is a Negative Regulator of Estrogen Receptor-Mediated Transcription
Ikeda, K., Ogawa, S., Tsukui, T., Horie‐Inoue, K., Ouchi, Y., Kato, S., Muramatsu, M., & Inoue, S. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0308 · Cited by 53
Challenging estrogen receptor β with phosphorylation
Sanchez, M., Picard, N., Sauvé, K., & Tremblay, A. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.09.007 · Cited by 52
Yamashita, H., Takahashi, S., Ito, Y., Yamashita, T., Ando, Y., Toyama, T., Sugiura, H., Yoshimoto, N., Kobayashi, S., Fujii, Y., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01274.x · Cited by 52
Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells
Behrens, D., Gill, J. H., & Fichtner, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.012 · Cited by 51
Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
Urbinati, G., Marsaud, V., Plassat, V., Fattal, E., Lesieur, S., & Renoir, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.046 · Cited by 50
Self-citationAn Inherent Role of Integrin-Linked Kinase-Estrogen Receptor α Interaction in Cell Migration
Acconcia, F., Manavathi, B., Mascarenhas, J. B., Talukder, A. H., Mills, G. B., & Kumar, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2676 · Cited by 49
St-Laurent, V., Sanchez, M., Charbonneau, C., & Tremblay, A. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.02.001 · Cited by 49
Auricchio, F., Migliaccio, A., & Castoria, G. (2008) · Steroids · doi:10.1016/j.steroids.2008.01.023 · Cited by 46
Tsai, H., Katzenellenbogen, J. A., Katzenellenbogen, B. S., & Shupnik, M. A. (2004) · Endocrinology · doi:10.1210/en.2003-1470 · Cited by 45
Sanchez, M., Sauvé, K., Picard, N., & Tremblay, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607908200 · Cited by 44
Hamilton-Burke, W., Coleman, L., Cummings, M., Green, C. A., Holliday, D. L., Horgan, K. J., Maraqa, L., Peter, M. B., Pollock, S., Shaaban, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090886 · Cited by 42
Skliris, G. P., Rowan, B. G., Al-Dhaheri, M. H., Williams, C., Troup, S., Begic, S., Parisien, M., Watson, P. H., & Murphy, L. C. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0267-z · Cited by 38
The future of breast cancer: the role of prognostic factors
Gradishar, W. J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-0144-y · Cited by 37
Binding of estrogen receptor α/β heterodimers to chromatin in MCF-7 cells
Papoutsi, Z., Zhao, C., Putnik, M., Gustafsson, J.-Α., & Dahlman‐Wright, K. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0177 · Cited by 36
Jensen, E. V. (1991) · Current topics in pathology · doi:10.1007/978-3-642-75515-6_11 · Cited by 35
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells.
Auricchio, F., Domenico, M. D., Migliaccio, A., Castoria, G., & Bilancio, A. (1995) · PubMed · Cited by 34
Akt stabilizes estrogen receptor α with the concomitant reduction in its transcriptional activity
Park, S., Song, J., Joe, C. O., & Shin, I. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.03.004 · Cited by 32
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha
Weitsman, G. E., Weebadda, W. K. C., Ung, K., & Murphy, L. C. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0221-0 · Cited by 32
Britton, D. J., Scott, G. K., Schilling, B., Atsriku, C., Held, J. M., Gibson, B. W., Benz, C. C., & Baldwin, M. A. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.02.008 · Cited by 30
Mutation of Serines 104, 106, and 118 Inhibits Dimerization of the Human Estrogen Receptor in Yeast
Sheeler, C. Q., Singleton, D. W., & Khan, S. (2003) · Endocrine Research · doi:10.1081/erc-120022321 · Cited by 29
Kim, M. Y., Woo, E. M., Ting, Y., Chong, E. G., Homenko, D. R., & Kraus, W. L. (2007) · Cited by 26
Cited by
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Molecular mechanism of estrogen–estrogen receptor signaling
Yaşar, P., Ayaz, G., User, S. D., Güpür, G., & Muyan, M. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12006 · Cited by 482
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076834 · Cited by 382
Liang, J., & Shang, Y. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 314
Gérard, C., & Brown, K. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.014 · Cited by 136
Metadata
- Authors
- Le Romancer, M., Poulard, C., Cohen, P., Sentis, S., Renoir, J.-M., & Corbo, L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2011-06-15
- Volume
- 32
- Issue
- 5
- Pages
- 597-622
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2121971175
- Cited by
- 313
- References
- 255
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.